+
Site Tour

Search

Showing 81 - 90 of 447 results.

  • Overview

    WATCH HOW TRICLIP™ TEER TRANSFORMED CRUZ'S LIFE 0 FIND OUT MORE: DOWNLOAD FLYER 0 FIND OUT MORE: TRICUSPID REGURGITATION   TREATMENT OPTIONS   CLINICAL DATA …
  • Clinical Data

    0 MitraClip™ + GDMT patients were more likely to be in NYHA functional class I or II throughout the 5 years 0 MitraClip™ + GDMT patients benefited from a 47% relative risk reduction in HFH/ Death…
  • Features

    MITRACLIP™ SUCCESSFULLY TREATS A BROAD RANGE OF VALVE ANATOMIES IN REAL-WORLD USE8,9   NEARLY 1 IN 5 PATIENTS TREATED HAVE VALVE ANATOMIES CONSIDERED COMPLEX8 Valve anatomies include:…
  • Patients who benefit

    49% of patients with symptomatic severe MR were not operated due to age, co-morbidities, or impaired LV.5 If left untreated, MR initiates a cascade of events leading to death, with 1-year…
  • Overview

    WATCH HOW MITRACLIP™ TEER TRANSFORMED LUCA'S LIFE 0 FIND OUT MORE: DOWNLOAD FLYER 0
  • Classification

    aThis algorithm can be applied to all patients with advanced HF defined according to the HFA-ESC criteria,5 with exception of hypertrophic cardiomyopathy (HCM), cardiac arrest (CA), arrhythmic…
  • Treatment

    Patients may also receive a remote monitoring system which allows them to transmit data to the doctor without an in-office visit. 0 CLASS II Slight limitation of physical activity. Comfortable at…
  • Diagnosis

    Figure 1: The diagnostic algorithm for heart failure. BNP=B-type natriuretic peptide; ECG=electrocardiogram; HFmrEF=heart failure with mildly reduced ejection fraction; HFpEF=heart failure with…
  • Overview

    HEART FAILURE IS AFFECTING A GROWING NUMBER OF PATIENTS 0 With the complexity and rise in prevalence of heart failure, the Heart Failure Association of the European Society of Cardiology aims to…
  • Overview

    FIND OUT MORE: AMPLATZER™ DUCT OCCLUDERS   AMPLATZER™ PICCOLO™ OCCLUDER 0 ABBOTT EVENTS PremiClose is the only worldwide symposium focused on PDA closure in preterm infants. The…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline